skip to main content

Yellow Card reporting — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyAdverse Drug Reactions and Drug SafetyYellow Card reportingGPhC CRA

A patient develops facial swelling and urticaria within an hour of taking a newly prescribed antibiotic. The reaction settles after urgent care treatment and she asks whether anyone should report it. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Submit or encourage an MHRA Yellow Card report

Suspected adverse drug reactions, particularly serious reactions, should be reported through the MHRA Yellow Card scheme. The allergy details should also be documented clearly in the patient's record. Rechallenge at home could be dangerous. Reporting supports pharmacovigilance and future patient safety.

Reference: MHRA Yellow Card; GPhC Standards